| ○種別 (必須): |
| ○言語 (必須): | □ | 英語
| [継承] |
| ○招待 (推奨): |
| ○審査 (推奨): |
| ○カテゴリ (推奨): |
| ○共著種別 (推奨): |
| ○学究種別 (推奨): |
| ○組織 (推奨): |
| ○著者 (必須): | 1. | (英) Yoshioka Takuya (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 2. | (英) Daizumoto Kei (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 3. | (英) Tada Kouki (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 4. | (英) Mima Masato (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 5. | (英) Kagawa Kozo (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 6. | (英) Fukawa Tomoya (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 7. | (英) Yamaguchi Kunihisa (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 8. | (英) Takahashi Masayuki (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 9. | 金山 博臣
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 10. | (英) Kanayama Hiroomi (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| ○題名 (必須): | □ | (英) Retroperitoneal hemorrhage in a patient with coronavirus disease 2019 (COVID-19):A case report. (日)
| [継承] |
| ○副題 (任意): |
| ○要約 (任意): | □ | (英) Early prophylactic administration of anticoagulants is recommended in patients with coronavirus disease 2019 (COVID-19). A case of retroperitoneal hemorrhage during inpatient treatment for COVID-19 is reported. A 69-year-old man was diagnosed with COVID-19 6 days after symptom onset. After admission for difficulty of breathing, he was treated with steroid pulse therapy, remdesivir, and heparin sodium. On day 16 after admission, his hemoglobin and blood pressure dropped. Computed tomography showed a left retroperitoneal hematoma and multiple areas of extravasation in bilateral iliopsoas muscles. Anticoagulation therapy was stopped, and blood transfusion therapy was chosen by considering poor general condition caused by severe pneumonia. On day 19, the hemoglobin and blood pressure improved, and blood transfusion was stopped. However, he died on day 25 due to pneumonia. When retroperitoneal hemorrhage occurs as a complication of COVID-19, appropriate treatment decision, transcatheter arterial embolization or conservative treatment, should be chosen based on patient's condition. J. Med. Invest. 69 : 148-151, February, 2022. (日)
| [継承] |
| ○キーワード (推奨): | 1. | (英) Aged (日) (読)
| [継承] |
| 2. | (英) Anticoagulants (日) (読)
| [継承] |
| 3. | 新型コロナ感染症 (COVID-19)
| [継承] |
| 4. | (英) Hemoglobins (日) (読)
| [継承] |
| 5. | (英) Hemorrhage (日) (読)
| [継承] |
| 6. | (英) Heparin (日) (読)
| [継承] |
| 7. | (英) Humans (日) (読)
| [継承] |
| 8. | 男性 (male)
| [継承] |
| ○発行所 (推奨): |
| ○誌名 (必須): | □ | The Journal of Medical Investigation : JMI ([徳島大学.医学部])
(pISSN: 1343-1420, eISSN: 1349-6867)
| ○ISSN (任意): | □ | 1349-6867
ISSN: 1343-1420
(pISSN: 1343-1420, eISSN: 1349-6867) Title: The journal of medical investigation : JMITitle(ISO): J Med InvestSupplier: 徳島大学Publisher: University of Tokushima (NLM Catalog)
(Webcat Plus)
(医中誌Web)
(J-STAGE)
(Scopus)
(CrossRef)
(Scopus information is found. [need login]) | [継承] |
| [継承] |
| ○巻 (必須): | □ | 69
| [継承] |
| ○号 (必須): | □ | 1.2
| [継承] |
| ○頁 (必須): | □ | 148 151
| [継承] |
| ○都市 (任意): |
| ○年月日 (必須): | □ | 西暦 2022年 0月 初日 (令和 4年 0月 初日)
| [継承] |
| ○URL (任意): |
| ○DOI (任意): | □ | 10.2152/jmi.69.148 (→Scopusで検索)
| [継承] |
| ○PMID (任意): | □ | 35466138 (→Scopusで検索)
| [継承] |
| ○CRID (任意): |
| ○WOS (任意): |
| ○Scopus (任意): |
| ○評価値 (任意): |
| ○被引用数 (任意): |
| ○指導教員 (推奨): |
| ○備考 (任意): | 1. | (英) Article.ELocationID: 10.2152/jmi.69.148 (日)
| [継承] |
| 2. | (英) Article.PublicationTypeList.PublicationType: Case Reports (日)
| [継承] |
| 3. | (英) Article.PublicationTypeList.PublicationType: Journal Article (日)
| [継承] |
| 4. | (英) KeywordList.Keyword: COVID-19 (日)
| [継承] |
| 5. | (英) KeywordList.Keyword: TAE (日)
| [継承] |
| 6. | (英) KeywordList.Keyword: anticoagulants (日)
| [継承] |
| 7. | (英) KeywordList.Keyword: nafamostat (日)
| [継承] |
| 8. | (英) KeywordList.Keyword: retroperitoneal hemorrhage (日)
| [継承] |